[Clinical experience with a treatment of threatened premature delivery with the aid of a beta-mimetic drug (author's transl)].
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D001317:Austria; D001724:Birth Weight; D005260:Female; D005865:Gestational Age; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D007263:Infusions, Parenteral; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D010627:Phenethylamines / Q000008:administration & dosage / Q000627:therapeutic use*; D010636:Phenols / Q000008:administration & dosage / Q000627:therapeutic use; D011247:Pregnancy; D011412:Propanolamines / Q000008:administration & dosage / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000008:administration & dosage / Q000627:therapeutic use*
D000318:Adrenergic beta-Agonists; D010627:Phenethylamines; D010636:Phenols; D011412:Propanolamines; D013566:Sympathomimetics
Klinische Erfahrungen bei der Behandlung der drohenden Frühgeburt mit einen beta-Mimetikum.